Literature DB >> 11032762

p53 codon 72 polymorphism as a risk factor in the development of breast cancer.

E N Papadakis1, D N Dokianakis, D A Spandidos.   

Abstract

The p53 gene is polymorphic at amino acid 72 of the protein that it encodes. It has been reported that patients with the arginine form have a higher risk of developing other forms of cancer than those with the proline form. The purpose of this study was to examine whether p53 Arg at the polymorphic position 72 could represent a risk factor for women with breast lesions. The study population included 56 biopsies from patients with breast lesions. Also, 61 normal blood samples were used as controls. There was a difference in the distribution of p53 genotypes between breast cancer lesions and the normal samples. The allele frequency of p53 Arg/Arg was much higher than that of the normal samples (61% versus 20%). Based on the findings of this study, it is suggested that p53 Arg homozygosity could represent a risk factor for the tumorigenesis of the breast. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11032762     DOI: 10.1006/mcbr.2000.0241

Source DB:  PubMed          Journal:  Mol Cell Biol Res Commun        ISSN: 1522-4724


  25 in total

1.  P53 Codon 72 polymorphisms: a case-control study of gastric cancer and potential interactions.

Authors:  James Sul; Guo-Pei Yu; Qing-Yi Lu; Ming-Lan Lu; Veronica Wendy Setiawan; Ming-Rong Wang; Chun Hua Guo; Shun-Zhang Yu; Lina Mu; Lin Cai; Robert C Kurtz; Zuo-Feng Zhang
Journal:  Cancer Lett       Date:  2005-08-19       Impact factor: 8.679

2.  Lack of correlation between p53 codon 72 polymorphism and anal cancer risk.

Authors:  Simone S Contu; Grasiela Agnes; Andrea P Damin; Paulo C Contu; Mário A Rosito; Claudio O Alexandre; Daniel C Damin
Journal:  World J Gastroenterol       Date:  2009-09-28       Impact factor: 5.742

3.  p53 Pro72Arg polymorphism and prostate cancer in men of African descent.

Authors:  L Ricks-Santi; T Mason; V Apprey; C Ahaghotu; A McLauchlin; D Josey; G Bonney; G M Dunston
Journal:  Prostate       Date:  2010-12-01       Impact factor: 4.104

4.  Establishment and characterization of six human lung cancer cell lines: EGFR, p53 gene mutations and expressions of drug sensitivity genes.

Authors:  Ja-Lok Ku; Kyung-Hee Kim; Jin-Sung Choi; You-Kyung Jeon; Sung-Hee Kim; Young-Kyoung Shin; Tae-You Kim; Yung-Jue Bang; Woo Ho Kim; Jae-Gahb Park
Journal:  Cell Oncol (Dordr)       Date:  2011-02-02       Impact factor: 6.730

5.  Association of p53 (-16ins-pro) haplotype with the decreased risk of differentiated thyroid carcinoma in Iranian-Azeri patients.

Authors:  Roghayeh Dehghan; Mohammad Ali Hosseinpour Feizi; Nasser Pouladi; Esmaeil Babaei; Vahid Montazeri; Ashraf Fakhrjoo; Ayda Sedaei; Parvin Azarfam; Masoumeh Nemati
Journal:  Pathol Oncol Res       Date:  2014-11-20       Impact factor: 3.201

6.  The discrepancy between genetic polymorphism of p53 codon 72 and the expression of p53 protein in Helicobacter pylori-associated gastric cancer in Korea.

Authors:  Nayoung Kim; Sung-Il Cho; Hye Seung Lee; Ji Hyun Park; Jee Hyun Kim; Joo Sung Kim; Hyun Chae Jung; In Sung Song
Journal:  Dig Dis Sci       Date:  2009-01-29       Impact factor: 3.199

7.  Analysis of p53 gene polymorphisms and protein over-expression in patients with breast cancer.

Authors:  Mustafa Akkiprik; Ozgur Sonmez; Bahadir M Gulluoglu; Hale B Caglar; Handan Kaya; Pakize Demirkalem; Ufuk Abacioglu; Meric Sengoz; Aydin Sav; Ayse Ozer
Journal:  Pathol Oncol Res       Date:  2009-09       Impact factor: 3.201

8.  The p53 codon 72 polymorphism is associated with risk and early onset of breast cancer among Saudi women.

Authors:  Abeer Al-Qasem; Mohamed Toulimat; Asma Tulbah; Naser Elkum; Taher Al-Tweigeri; Abdelilah Aboussekhra
Journal:  Oncol Lett       Date:  2012-01-24       Impact factor: 2.967

9.  Breast cancer risk in relation to TP53 codon 72 and CDH1 gene polymorphisms in the Bangladeshi women.

Authors:  Samia Shabnaz; Maizbha Uddin Ahmed; Md Siddiqul Islam; Md Reazul Islam; Mir Md Abdullah Al-Mamun; Mohammad Safiqul Islam; Abul Hasnat
Journal:  Tumour Biol       Date:  2015-12-14

10.  Phosphodiesterase 11A (PDE11A) and genetic predisposition to adrenocortical tumors.

Authors:  Rossella Libé; Amato Fratticci; Joel Coste; Frédérique Tissier; Anelia Horvath; Bruno Ragazzon; Fernande Rene-Corail; Lionel Groussin; Xavier Bertagna; Marie Laure Raffin-Sanson; Constantine A Stratakis; Jérome Bertherat
Journal:  Clin Cancer Res       Date:  2008-06-15       Impact factor: 12.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.